{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:42:32Z","timestamp":1787010152967,"version":"build-2736575974"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"51","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1097\/md.0000000000009327","type":"journal-article","created":{"date-parts":[[2017,12,21]],"date-time":"2017-12-21T21:41:16Z","timestamp":1513892476000},"page":"e9327","source":"Crossref","is-referenced-by-count":29,"title":["Skeletal-related events and overall survival of patients with bone metastasis from nonsmall cell lung cancer \u2013 A retrospective analysis"],"prefix":"10.1097","volume":"96","author":[{"given":"Pengyu","family":"Kong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinglong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinpeng","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jincai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolong","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-96-20210226","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.lungcan.2011.05.022","article-title":"Randomized phase II study of gefitinib versus erlotinib in patients with advanced non-small cell lung cancer who failed previous chemotherapy","volume":"75","author":"Kim","year":"2012","journal-title":"Lung Cancer"},{"key":"R2-96-20210226","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0025-6196(11)60735-0","article-title":"Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship","volume":"83","author":"Molina","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"R3-96-20210226","doi-asserted-by":"crossref","first-page":"e185","DOI":"10.1371\/journal.pmed.0050185","article-title":"Lung cancer occurrence in never-smokers: an analysis of 13 cohorts and 22 cancer registry studies","volume":"5","author":"Thun","year":"2008","journal-title":"PLoS Med"},{"key":"R4-96-20210226","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/1759-7714.12169","article-title":"Epidemiology of lung cancer in China","volume":"6","author":"Chen","year":"2015","journal-title":"Thorac Cancer"},{"key":"R6-96-20210226","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1056\/NEJMoa061884","article-title":"Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer","volume":"355","author":"Sandler","year":"2006","journal-title":"N Engl J Med"},{"key":"R7-96-20210226","doi-asserted-by":"crossref","first-page":"18670","DOI":"10.1038\/srep18670","article-title":"Natural history of non-small-cell lung cancer with bone metastases","volume":"5","author":"Daniele","year":"2015","journal-title":"Sci Rep"},{"key":"R8-96-20210226","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1378\/chest.12-1717","article-title":"Prognostic factors and the significance of treatment after recurrence in completely resected stage I non-small cell lung cancer","volume":"143","author":"Shimada","year":"2013","journal-title":"Chest"},{"key":"R9-96-20210226","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s13277-015-3907-z","article-title":"Risk factors for skeletal-related events (SREs) and factors affecting SRE-free survival for nonsmall cell lung cancer patients with bone metastases","volume":"37","author":"Ulas","year":"2016","journal-title":"Tumour Biol"},{"key":"R10-96-20210226","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/cncr.20308","article-title":"Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors: a randomized, phase III, double-blind, placebo-controlled trial","volume":"100","author":"Rosen","year":"2004","journal-title":"Cancer"},{"key":"R11-96-20210226","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.lungcan.2008.10.026","article-title":"Risk factors for skeletal-related events in patients with non-small cell lung cancer treated by chemotherapy","volume":"65","author":"Sekine","year":"2009","journal-title":"Lung Cancer"},{"key":"R12-96-20210226","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1053\/ctrv.2000.0210","article-title":"Metastatic bone disease: clinical features, pathophysiology and treatment strategies","volume":"27","author":"Coleman","year":"2001","journal-title":"Cancer Treat Rev"},{"key":"R13-96-20210226","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1634\/theoncologist.9-90004-14","article-title":"Bisphosphonates: clinical experience","volume":"9","author":"Coleman","year":"2004","journal-title":"Oncologist"},{"key":"R15-96-20210226","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"key":"R16-96-20210226","first-page":"4131","article-title":"Feasibility study of zoledronic acid plus cisplatin-docetaxel as first-line treatment for advanced non-small cell lung cancer with bone metastases","volume":"32","author":"Yoh","year":"2012","journal-title":"Anticancer Res"},{"key":"R17-96-20210226","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.lungcan.2007.03.013","article-title":"Skeletal metastases in non-small cell lung cancer: a retrospective study","volume":"57","author":"Tsuya","year":"2007","journal-title":"Lung Cancer"},{"key":"R18-96-20210226","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.lungcan.2014.08.022","article-title":"Bone metastasis, skeletal-related events, and mortality in lung cancer patients: a Danish population-based cohort study","volume":"86","author":"Cetin","year":"2014","journal-title":"Lung Cancer"},{"key":"R19-96-20210226","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.lungcan.2010.04.003","article-title":"Predictors of skeletal-related events in non-small cell lung cancer patients with bone metastases","volume":"71","author":"Sun","year":"2011","journal-title":"Lung Cancer"},{"key":"R20-96-20210226","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s00520-015-2835-1","article-title":"Skeletal related events in patients with bone metastasis arising from non-small cell lung cancer","volume":"24","author":"da Silva","year":"2016","journal-title":"Support Care Cancer"},{"key":"R22-96-20210226","first-page":"757","article-title":"A case of recurrent lung cancer with bone metastases treated with tegafur-uracil and zoledronic acid for long-term survival","volume":"41","author":"Shiono","year":"2014","journal-title":"Gan To Kagaku Ryoho"},{"key":"R23-96-20210226","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s11999-007-0051-0","article-title":"Predictors of survival in patients with bone metastasis of lung cancer","volume":"466","author":"Sugiura","year":"2008","journal-title":"Clin Orthop Relat Res"},{"key":"R24-96-20210226","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1002\/cncr.11701","article-title":"Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, double-blind, multicenter, comparative trial","volume":"98","author":"Rosen","year":"2003","journal-title":"Cancer"},{"key":"R25-96-20210226","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3111\/13696998.2011.650489","article-title":"Retrospective evaluation of the clinical benefit of long-term continuous use of zoledronic acid in patients with lung cancer and bone metastases","volume":"15","author":"Henk","year":"2012","journal-title":"J Med Econ"},{"key":"R26-96-20210226","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1097\/JTO.0000000000000630","article-title":"The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification","volume":"10","author":"Travis","year":"2015","journal-title":"J Thorac Oncol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000009327","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T22:48:33Z","timestamp":1620946113000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201712220-00096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":23,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000009327","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]}}}